With several products currently in the clinic and a compelling long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company. Combining our expertise in antibody engineering with a disciplined, biology-driven research approach, our company is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs. We are passionate and committed about the work that we do, and we share a common goal of developing therapeutics that will improve people’s lives.
Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.
|
|
|
|
|
201-500 employees
View all Facet Biotech employees
|
|
|
Biotechnology Research
|
|
|
, US
|
|
|
2008
|
|
|
Biotechnology, Oncology, Immunology, Antibody Engineering
|
Abanish Behera is the CEO of Facet Biotech. To contact Abanish Behera email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.